Innovation Center for Advanced Therapies (ICAT)

Today, we were delighted to host ReGEN Biomedical, part of the RegMed XB pilot factory, at our facility for an inspiring visit focused on exploring and strengthening our collaboration. 🤝 Together, we discussed ways to combine our expertise and infrastructure to push the boundaries of regenerative medicine and bring innovative solutions closer to patients. Looking forward to the progress we can achieve together! 🚀 #ICAT #RegenBiomedical #RegMedXB #RegenerativeMedicine #Collaboration #Innovation #HealthcareTransformation

Our colleagues from the RegMed XB #PilotFactory will be attending the BIO-Europe conference: Sophia Kolbe from NecstGen, Joost van Duijn from Innovation Center for Advanced Therapies (ICAT) and Danielle Trappenburg - Eelkman Rooda from Smart BioMaterials Consortium (SBMC).   If you're attending, let’s connect to explore opportunities in #ATMP and biomaterial development!   #BIOEurope #RegenerativeMedicine #Networking #Innovation #Stockholm #LifeScience #Sweden #Meet #Conference 

Looking forward to representing the Innovation Center for Advanced Therapies (ICAT) at BIO-Europe in Stockholm! If you'll be there, let's connect. It would be great to discuss collaboration opportunities and share the latest updates on Utrecht's ICAT and the RegMedXB Pilot Factory for Regenerative Medicine. Feel free to reach out! https://lnkd.in/eZ7sGnbs Informa Connect #ATMP #Regenerativemedicine #Biofabrication

Yesterday, Anil Kumar Deshantri, PhD showcased a poster presentation at the European Society of Gene and Cell Therapy (ESGCT) Conference in Rome where he highlighted Innovation Center for Advanced Therapies (ICAT)’s sub-facilities, expertise and the role of GMP Simulation facility in the field of ATMP development and regenerative medicine. ✨ It was an engaging day with insightful discussions and strong interest from like-minded attendees eager to learn more about our progress and innovations. The event was perfect for building new partnerships to advance the clinical translation of ATMP's and regenerative medicine worldwide. 🤝 #ICAT #ESGCT #GeneTherapy #CellTherapy #RegenerativeMedicine #GMPSimulation #Networking #FutureOfHealthcare

Last Friday, we had the honor of welcoming Conny Helder, the new Chair of the Supervisory Board and the Chief Operating Officer, Erik Eijrond of RegMed XB, to our Innovation Center for Advanced Therapies (ICAT) facility at Utrecht Science Park in Zeist. During her visit, both visitors received an in-depth presentation and lab tour of our facility. It was a fantastic opportunity to showcase our cutting-edge projects in regenerative medicine and highlight the strength of this ecosystem. Conny Helder’s dedication to making healthcare more accessible, affordable, and future-proof aligns perfectly with our mission to develop regenerative therapies that can cure patients suffering from chronic diseases. We look forward to continued collaboration and are excited about the future of regenerative medicine in the Netherlands and beyond! 🌍 #RegenerativeMedicine #Innovation #Healthcare #ICAT #RegMedXB #PilotFactory #Collaboration #FutureOfHealth

Three National Growth Fund-initiatives sign collaboration agreement Following their joint statement earlier this month, three consortia; Biotech Booster, Oncode Accelerator and RegMed XB- gathered at their joint office today to sign the agreement marking the official start of their collaboration. More collaboration agreements with key partners, such as NXTGEN Hightech, will follow soon. The #collaboration is rooted in a shared vision of fostering #innovation and improving human #health and is focused on - but certainly not limited to - driving the development of advanced therapy medicinal products (#ATMP’s) and #biopharmaceuticals in order to provide novel treatments for a spectrum of diseases ranging from cancer to autoimmune diseases. Click here to read the press release and find out how the collaboration will take shape! 👉 https://lnkd.in/eW-qY2_C Nettie Buitelaar | Bernard Mulder | Friso Smit Nationaal Groeifonds

🚀 Driving Interdisciplinary Collaboration in Research 🚀 Yesterday at the Research Days at UMC Utrecht, Innovation Center for Advanced Therapies (ICAT) participated in an insightful panel discussion with Jos Malda (UMC Utrecht), Eva van Ingen, PhD (ICAT), Paulina Nunez Bernal (Biofabrication), and Chien Nguyen (3D Lab) on how team science fosters interdisciplinary collaboration, enhances innovation, and supports researchers' professional development. Jos Malda shared success stories from his team during his keynote lecture, highlighting the significant impact of teamwork on scientific progress. Following the panel, ICAT was present at the Healthcare and Laboratories of the Future event, where we engaged with attendees to discuss how we bridge research and clinical practice, our services, and the value of our network. It was a fantastic opportunity to connect with interested professionals! #TeamScience #UtrechtScienceWeek #InterdisciplinaryResearch #Innovation #Collaboration #ProfessionalDevelopment #ICAT #Healthcare

Last Night, Regenerative Medicine Utrecht and UMC Utrecht organized a public event "The Hospital of the Future" as part of the Utrecht Science Week. During this evening, current and future clinical applications of cell and gene therapies (ATMPs) were presented. It was inspiring to see what the hard work of the Cell Therapy Facility (CTF) team and Hospital Pharmacy of the UMC Utrecht has contributed to these novel treatments by producing many of these therapies. During the breaks, part of the CTF team: Vince Sindhunata, Ilse Dingjan, Martine Jonker, Lieneke Meijer-Jongeneel, Christien Marsman and Madeleine Macco, together with our colleagues from ICAT interacted with participants to explain what it takes to develop and produce ATMPs for clinical applications. They also provided a virtual tour through our new clean room facility currently under construction.

Yesterday, Innovation Center for Advanced Therapies (ICAT) participated in the 'Public Evening – Hospital of the Future' together with our GMP Production Facility. 🎉 Our colleagues, Colin de Haar, Joost van Duijn and Eva van Ingen, PhD, engaged in conversations about the challenge of translating the findings of researchers into everyday clinical applications. We are grateful for the opportunity to connect with so many people and share insights on how Innovation Center for Advanced Therapies (ICAT) translates innovations to patient care in hospitals! 🌟 #ICAT #GMPProductionFacility #Innovation #FutureOfHealthcare #PatientCare #Collaboration

Groen licht voor een nieuwe studie naar stamceltherapie voor pasgeborenen met hersenschade. De werkzaamheid van deze veelbelovende therapie kan nu worden getest.   Baby’s met een herseninfarct of met zuurstoftekort tijdens de bevalling kunnen ernstige schade aan hun hersenen oplopen. Deze schade kan leiden tot blijvende neurologische problemen.   Neurowetenschapper Cora Nijboer en kinderarts en hoogleraar Manon Benders ontwikkelden een nieuwe therapie op basis van neusdruppels, met daarin een specifiek soort stamcellen, afkomstig van gezonde donoren. "De stamcellen helpen ontstekingen verminderen en stimuleren de aanmaak van nieuwe hersencellen", aldus Cora. Uit opvolgend onderzoek bleek dat de stamcelneusdruppels veilig kunnen worden toegediend. Dankzij een subsidie van in totaal 5 miljoen euro van Zorginstituut Nederland, ZonMw, de Hersenstichting en de Vrienden UMC Utrecht kan de nieuwe studie, genaamd iSTOP-CP van start. De studie wordt ook gesteund door het Maastricht UMC+, met wie we een langlopende samenwerking hebben op dit onderzoek.   Verschillende patiëntenverenigingen, waaronder Care4Neo en CP Nederland, steunen deze belangrijke studie. ➡ Lees meer via: https://lnkd.in/gd-sdRgy #StamcelTherapie #Hersenschade #Hersenletsel #KindZorg #ChildHealth #BrainResearch | Wilhelmina Kinderziekenhuis (WKZ) | Child Health UMC Utrecht UMC Utrecht Brain Center